A study on optimization of the CAR-γδ T cell manufacturing process
Background and purpose: In recent years, chimeric antigen receptor T (CAR-T) cell therapy has achieved breakthrough progress in cancer treatment. γδ T cells, with their non-major histocompatibility complex (MHC)-restricted antigen recognition, broad antitumor activity, and low risk of graft-versus-h...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Editorial Office of China Oncology
2025-11-01
|
| Schriftenreihe: | Zhongguo aizheng zazhi |
| Schlagworte: | |
| Online-Zugang: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.11.004 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|